e-learning
resources
Munich 2014
Sunday, 07.09.2014
Three smoking-related diseases: cardiovascular, lung cancer and infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of smoking dosage and chronic obstructive lung disease on the incidence of appropriate therapies and mortality in patients with structural heart disease and an implantable cardioverter defibrillator
J. Kreuz, J. Schwab, G. Nickenig, D. Skowasch (Bonn, Germany)
Source:
International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Session:
Three smoking-related diseases: cardiovascular, lung cancer and infection
Session type:
Poster Discussion
Number:
326
Disease area:
Airway diseases
Abstract
ObjectivesThis study was initiated to explore the influence of smoking dosage and presence of chronic obstructive lung disease (COPD) on the incidence of appropriate implantable cardioverter defibrillator (ICD) interventions and on mortality.BackgroundPrior studies on ICD patients suggested that nicotine consumption increases the risk of experiencing an appropriate ICD therapy. There is no substantial data regarding the influence of cigarette smoking dosage on overall mortality in such endangered patients.Methods349 patients with structural heart disease equipped with an ICD were included. Every patient answered a questionnaire regarding his smoking status and performed a spirometry and body plethysmography.Results104 patients (30%) suffered from COPD. 58 patients (17%) were current smokers, 196 patients (56%) revealed as former smokerswhile 93 (27%) patients were registered as never smokers. 163 patients (47%) received at least one appropriate ICD intervention during follow up (median 48+/-8 months). Twenty-three patients died during this study (6.6%). There was no association of COPD with the incidence of appropriate ICD therapies or mortality. Smoking dosage revealed as a significant risk factor for both appropriate ICD interventions (hazard ratio (HR) 1.5 for 60 pack years (PY) p=0.04) and mortality (HR 2.3 for 60 PY p=0.02).DiscussionThis study demonstrates a dose related increased risk of smokers for appropriate ICD interventions and mortality. The results of this trail urge a strict nicotine abstinence, especially in ICD patients with a structural heart disease.
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kreuz, J. Schwab, G. Nickenig, D. Skowasch (Bonn, Germany). Influence of smoking dosage and chronic obstructive lung disease on the incidence of appropriate therapies and mortality in patients with structural heart disease and an implantable cardioverter defibrillator. Eur Respir J 2014; 44: Suppl. 58, 326
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Evaluation of smoking cessation among patients with respiratory or cardiac disease after 6 months of hospitalization
Source: International Congress 2014 – Twenty views of smoking cessation and physical activity
Year: 2014
The prevalence and impact of cannabis smoking in clinical trial patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
Evaluation of arrhythmia frequency in patients with COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015
Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy
Source: Eur Respir J 2007; 29: 390-417
Year: 2007
Global and regional trends in mortality from chronic obstructive pulmonary disease: Their relation to poverty, smoking and population change
Source: International Congress 2014 – New insights into the epidemiology of COPD
Year: 2014
Evaluation of the effect of quit smoking with arteriosclerosis index in COPD patients
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014
Influence of tobacco smoking on adhesion molecules profiles in patients with chronic obstructive lung disease
Source: International Congress 2014 – Passive smoking, active smoking and COPD
Year: 2014
Influence of smoking on respiratory function and status of proteinas-inhibitory system in patients COPD
Source: International Congress 2014 – Passive smoking, active smoking and COPD
Year: 2014
National epidemiological study of smoking cessation in danish patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence
Year: 2020
Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention
Source: Eur Respir J 2006; 28: 397-408
Year: 2006
Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Does self-management support increase the risk of mortality amongst patients with COPD? A systematic review of the evidence
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014
Characteristics and consequences of chronic obstructive pulmonary disease in never smokers
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Integrated disease management (IDM) intervention for COPD patients has long-term effects on patient activation
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Fear of falling and future falls in individuals with chronic obstructive pulmonary disease
Source: International Congress 2014 – Latest insights in physical activity, exercise testing and muscles
Year: 2014
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Dietary habits in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
One-year change in health status and outcomes in chronic obstructive pulmonary disease
Source: International Congress 2014 – Best abstracts in chronic care
Year: 2014
Metabolic profile of patients with chronic obstructive pulmonary disease in rehabilitation program
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014
Epidemiology of COPD
Source: Eur Respir Rev 2009; 18: 213-221
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept